They can inhibit insulin receptor signalling by inducing serine/threonine phosphorylation of insulin receptor substrates, leading to impaired insulin signalling and insulin resistance, as well as abnormal expansion and accumulation of adipocytes [21,22]. The gene discussed is INSR; the disease is Insulin resistance.